Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
RNAZ
#4268
TransCode Therapeutics, Inc. Common Stock
9.830
0
USD
+0.31%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
+0.31%
Monatliche Änderung
+3.39%
6 month change
+3.39%
Jahresänderung
+3.39%
Vorheriger Schlusskurs
9.800
0
Open
9.750
0
Bid
9.830
0
Ask
9.833
0
Low
9.750
0
High
9.830
0
Volumen
9
Märkte
Aktien
Gesundheitswesen
RNAZ
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.46
21.41
6 285.77
833.62 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.3
-2.31
-3.59
-2.3
-1.34
Return on equity %
-0.34
-5.42
-11.3
8.3
0.01
Return on invested capital %
-10.47 K
-33.53 K
-11.4 K
-23.65 K
-38.24 K
Gross margin %
100
—
—
100
400
Operating margin %
199.58 K
—
—
27.69 K
32.55 K
EBITDA margin %
—
—
—
—
—
Net margin %
222.04 K
—
—
29.62 K
-22.94 K
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
8.97
1.7
1.28
2.56
14.62
Inventory turnover
—
—
—
—
—
Asset turnover
-0
—
—
-0.01
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-462.06 K
899.99 K
-93.3 K
1 045.73
1 874.85
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
1.83 M
284.81 K
14.45 K
456.03
535.65
Net current asset value per share
1.99 M
420.34 K
23 K
557.72
649.03
Tangible book value per share
1.79 M
184.59 K
8 469.62
-158.73
-89.89
Working capital per share
1.77 M
172.71 K
4 980.39
339.78
411.09
Book value per share
1.79 M
184.59 K
8 469.62
-158.73
-89.89
Nachrichten
TransCode sichert sich Lizenz für Krebstherapie-Plattform von Unleash
TransCode licenses bladder cancer therapy platform from Unleash
TransCode-Aktie steigt um 40 % nach Antrag für klinische Studie zu Krebsmedikament
TransCode-Aktie schießt nach vielversprechender Glioblastom-Studie um 18 % in die Höhe
TransCode Therapeutics stock soars after promising glioblastoma study
TransCode Therapeutics appoints Jack E. Stover to board of directors
TransCode und Quantum Leap testen Krebstherapie in Phase-2a-Studie
TransCode and Quantum Leap to test cancer therapy in phase 2a trial
TransCode Therapeutics appoints Michel Janicot as development officer
Transcode Therapeutics ändert Bedingungen für Vorzugsaktien nach Aktionärszustimmung
Transcode Therapeutics amends preferred stock terms following shareholder approval
TransCode reports positive safety data from TTX-MC138 phase 1a trial